← Back to Clinical Trials
Recruiting NCT04163172

Elbow Hemiarthroplasty Versus ORIF for Distal Humeral Fractures

Trial Parameters

Condition Distal Humerus Fracture
Sponsor Herlev and Gentofte Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 44
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2020-02-01
Completion 2026-12-31
Interventions
Surgical treatment of distal humeral fracture with elbow hemiarthroplastySurgical treatment of distal humeral fracture with double plating.

Brief Summary

This is a randomized control trial comparing the outcome of ORIF (open reduction and internal fixation) with EHA (elbow hemiarthroplasty) for distal humeral fractures in patients aged 50 years or above.

Eligibility Criteria

Inclusion Criteria: 1. Distal humeral fracture AO/OTA type C2 or C3 confirmed by plain radiographs with 2 perpendicular views and CT scan. 2. ASA score 1-3 and physically fit for surgery. 3. Age of 50 years or above. Exclusion Criteria: 1. Patients unable to follow the rehabilitation protocol or answer the Danish questionnaires because of physical or cognitive inabilities as evaluated by the recruiting surgeon. 2. Significant elbow osteoarthritis as evaluated by the recruiting surgeon based on plain radiographs and CT scan. 3. Fractures that are older than 6 weeks. 4. Other associated elbow fractures. 5. Pathological fractures or relevant elbow pathology.

Related Trials